Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 10,000 shares at $13.34 ($134K) on 2022-09-15, disclosed to the SEC on 2022-09-16.
Open-market sale of $134k RXRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.34 | 9,600 | $128K | 95.8% |
| 2 | $13.97 | 400 | $6K | 4.2% |
| Total | $13.37 avg | 10,000 | $134K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |